In vitro hemorheological effects of red wine and alcohol-free red wine extract

Clinical Hemorheology and Microcirculation

Volumn 44, Issue 3, 2010, Pages 227-236

  Rabai, M ^a   Toth, A ^a   Kenyeres, P ^a   Mark, L ^a   Marton, Zs ^a   Juricskay, I ^a   Toth, K ^a   Czopf, L ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

erythrocyte aggregation; erythrocyte deformability; ethanol; platelet aggregation; Polyphenols

Indexed keywords

ALCOHOL DERIVATIVE; ALCOHOL FREE RED WINE EXTRACT; ANTHOCYANIN; ANTIOXIDANT; PHENAZINE METHOSULFATE; POLYPHENOL; SODIUM CHLORIDE; UNCLASSIFIED DRUG; ALCOHOL;

ALCOHOL BLOOD LEVEL; ARTICLE; BLOOD RHEOLOGY; BLOOD SAMPLING; CELL PROTECTION; CONTROLLED STUDY; ERYTHROCYTE AGGREGATION; ERYTHROCYTE DEFORMABILITY; HEART PROTECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; INHIBITION KINETICS; NORMAL HUMAN; RED WINE; THROMBOCYTE AGGREGATION; BLOOD; CARDIOVASCULAR DISEASES; CHEMISTRY; DRUG EFFECTS; WINE;

CARDIOVASCULAR DISEASES; ERYTHROCYTE DEFORMABILITY; ETHANOL; HEMORHEOLOGY; HUMANS; PLATELET AGGREGATION; WINE;

EID: 77954095700     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: 10.3233/CH-2010-1267     Document Type: Article

References (50)

1. L.H. Abou-Agag, N.K. Khoo, R. Binsack, C.R. White, V. Darley-Usmar, H.E. Grenett, F.M. Booyse, S.B. Digerness, F. Zhou and D.A. Parks, Evidence of cardiovascular protection by moderate alcohol: role of nitric oxide, Free Radic Biol Med 39 (2005), 540-548.
2. M.L. Aikens, H.E. Grenett, R.L. Benza, E.M. Tabengwa, G.C. Davis and F.M. Booyse, Alcohol-induced upregulation of plasminogen activators and fibrinolytic activity in cultured human endothelial cells, Alc Clin Exp Res 22 (1998), 375-381.
3. C. Auger, N. Al-Awwadi, J.M. Rounat, F. Gasc, G. Cros and P.L. Teissedre, Catechins and procyanidins in Mediterranean diets, Food Res Intern 37 (2004), 233-245.
4. P. Avar, M.S. Pour Nikfardjam, S. Kunsagi-Mate, G. Montsko, Z. Szabo, K. Böddi, R. Ohmacht and L. Mark, Investigation of phenolic components of Hungarian wines, Int J Mol Sci 8 (2007), 1028-1038.
5. O.K. Baskurt and H.J. Meiselman, Analyzing shear stress-elongation index curves: comparison of two approaches to simplify data presentation, Clin Hemorheol Microcirc 31 (2004), 23-30.
6. R.M. Bauersachs, R.B Wenby and H.J. Meiselman, Determination of specific red blood cell aggregation indices via an automated system, Clin Hemorheol 9 (1989), 1-25.
7. D.J. Boocock, G.E. Faust, K.R. Patel, A.M. Schinas, V.A. Brown, M.P. Ducharme, T.D. Booth, J.A. Crowell, M. Perloff, A.J. Gescher, W.P. Steward and D.E. Brenner, Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent, Cancer Epidemiol Biomark Prev 16 (2007), 1246-1252.
8. F.MBooyse and D.A. Parks, Moderate wine and alcohol consumption: beneficial effects on cardiovascular disease, Thromb Haemost 86 (2001), 517-528.
9. H.K. Breddin, Can platelet aggregometry be standardized? Platelets 16 (2005), 151-158.
10. P.J.H. Bronkhorst, E.J. Nijhof and J.J. Sixma, Parameterization of the deformation curve as a tool for standardization and interpretation of ektacytometric measurements, Clin Hemorheol 15 (1995), 803-816.
11. C. Casavecchia, R. Magnisi, L. La Pera, R. Maisano and G. Dugo, Classification of sicilian red wines from autochthonous and allochthonous cultivars according to anthocyanin pattern, Am J Enol Viticult 58 (2007), 286-290.
12. M. Chopra, P.E. Fitzsimons, J.J. Strain, D.I. Thurnham and A.N. Howard, Nonalcoholic red wine extract and quercetin inhibit LDL oxidation without affecting plasma antioxidant vitamin and carotinoid concentrations, Clin Chem 46 (2000), 1162-1170.
13. A. de Curtis, S. Murzilli, A. Di Castelnuovo, D. Rotilio, M.B. Donati, G. de Gaetano and L. Iacoviello, Alcohol-free red wine prevents arterial thrombosis in dietary-induced hypercholesterolemic rats: experimental support for the 'French paradox', J Thromb Haemost 3 (2005), 346-350.
14. D.W. de Lange,W.L. Scholman, R.J. Kraaijenhagen, J.W. Akkerman and A. van deWiel, Alcohol and polyphenolic grape extract inhibit platelet adhesion in flowing blood, Eur J Clin Invest 34 (2004), 818-824.
15. D.W. de Lange, P.H. Van Golden,W.L. Scholman, R.J. Kraaijenhagen, J.W. Akkerman and A. van deWiel, Red wine and red wine polyphenolic compounds but not alcohol inhibit ADP-induced platelet aggregation, Eur J Intern Med 14 (2003), 361-366.
16. D.W. de Lange, S. Verhoef, G. Gorter, R.J. Kraaijenhagen, A. van deWiel and J.W. Akkerman, Polyphenolic grape extract inhibits platelet activation through PECAM-1: an explanation for the French paradox, Alcohol Clin Exp Res 31 (2007), 1308-1314.
17. M. Donner, M. Siadat and J.F. Stoltz, Erythrocyte aggregation: approach by light scattering determination, Biorheol 25 (1988), 367-375.
18. A. Edelmann, J. Diewok, K.C. Schuster and B. Lendl, Rapid method for the discrimination of red wine cultivars based on mid-infrared spectroscopy of phenolic wine extracts, J Agric Food Chem 49 (2001), 1139-1145.
19. M. Fehr, K.S. Galliard-Grigioni and W.H. Reinhart, Influence of acute alcohol exposure on hemorheological parameters and platelet function in vivo and in vitro, Clin Hemorheol Microcirc 39 (2008), 351-358.
20. D.M. Goldberg, J.N.G.E. Yan, E.P. Diamandis, A. Karumanchiri, G. Soleas and A.L. Waterhouse, A global survey of trans-resveratrol concentrations in commercial wines, Am J Enol Vitic 46 (1995), 159-165.
21. M.R. Hardeman, J.G. Dobbe and C. Ince, The laser-assisted optical rotational cell analyzer (LORCA) as red blood cell aggregometer, Clin Hemorheol Microcirc 25 (2001), 1-11.
22. M.R. Hardeman, P.T. Goedhart, J.G.G Dobbe and K.R. Lettinga, Laser-assisted optical rotational red cell analyzer (LORCA). I: A new instrument for measurement of various structural hemorheological parameters, Clin Hemorheol 14 (1994), 605-618.
23. M.R. Hardeman, P.T. Goedhart and N.H. Schut, Laser-assisted optical rotational cell analyser (LORCA). II: Red blood cell deformability: elongation index versus cell transit time, Clin Hemorheol 14 (1994), 619-630.
24. B. Horvath, Zs. Marton, R. Halmosi, T. Alexy, L. Szapary, J. Vekasi, Zs. Biro, T. Habon, G. Kesmarky and K. Toth, In vitro antioxidant properties of pentoxifylline, piracetam and vinpocetine, Clin Neuropharmacol 25 (2002), 37-42.
25. P. Kenyeres, I. Juricskay, P. Tarsoly, G. Kesmarky, D. Mühl, K. Toth and L. Bogar, Low hematocrit per blood viscosity ratio as a mortality risk factor in coronary heart disease, Clin Hemorheol Microcirc 38 (2008), 51-56.
26. D. Kontkanen, A. Reynolds, M.A. Cliff and M. King, Canadian terroir: sensory characterization of Bordeaux-style red wine varieties in the Niagara Peninsula, Food Res Int 38 (2005), 417-425.
27. G. Kuhnle, J.P. Spencer, G. Chowrimootoo, H. Schroeter, E.S. Debnam, S.K. Srai, C. Rice-Evans and U. Hahn, Resveratrol is absorbed in the small intestine as resveratrol glucuronide, Biochem Biophys Res Commun 272 (2000), 212-217.
28. D. López, M. Pavelkova, L. Gallova, P. Simonetti, C. Gardana, A. Lojek, R. Loaiza and M.T. Mitjavila, Dealcoholized red and white wines decrease oxidative stress associated with inflammation in rats, Br J Nutr 98 (2007), 611-619.
29. Zs. Marton, R. Halmosi, B. Horvath, T. Alexy, G. Kesmarky, J. Vekasi, I. Battyany, K. Hideg and K. Toth, Scavenger effect of experimental and clinically used cardiovascular drugs, J Cardiovasc Pharmacol 38 (2001), 745-753.
30. M.V. McConnell, I. Vavouranakis, L.L. Wu, D.E. Vaughan and P.M. Ridker, Effects of a single, daily alcoholic beverage on lipid and hemostatic markers of cardiovascular risk, Am J Cardiol 80 (1997), 1226-1228.
31. Y. Nagai, K. Ishida, M. Hirooka and K. Nishimaru, Effect of ethanol on hemorheology in patients with ischemic cerebrovascular disease and elderly healthy men, Clin Hemorheol Microcirc 25 (2001), 135-144.
32. C.R. Pace-Asciak, S. Hahn, E.P. Diamandis, G. Soleas and D.M. Goldberg, The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease, Clin Chim Acta 235 (1995), 207-219.
33. S. Pal, N. Ho, C. Santos, P. Dubois, J. Mamo, K. Croft and E. Allister, Red wine polyphenolics increase LDL receptor expression and activity and suppress the secretion of ApoB100 from human HepG2 cells, J Nutr 133 (2003), 700-706.
34. A. Palfi, E. Bartha, L. Czopf, L. Mark, F. Gallyas, B. Veres, E. Kalman, L. Pajor, K. Toth, R. Ohmacht and B. Sumegi, Alcohol-free red wine extract inhibits isoproternol-induced cardiac remodeling in rats by the regulation of Akt1 and PKCα/β II, J Nutr Biochem 20 (2009), 418-425.
35. M.S. Pour Nikfardjam, L. Mark, P. Avar, M. Figler and R. Ohmacht, Polyphenols, anthocyanins, and trans-resveratrol in red wines from the Hungarian Villány region, Food Chem 98 (2006), 453-462.
36. S. Renaud and M. de Lorgeril, Wine, alcohol, platelets, and the French paradox for coronary heart disease, Lancet 339 (1992), 1523-1526.
37. S.C. Renaud and J.C. Ruf, Effects of alcohol on platelet functions, Clin Chim Acta 246 (1996), 77-89.
38. C.A. Rice-Evans, N.J. Miller and G. Paganga, Structure-antioxidant activity relationships of flavonoids and phenolic acids, Free Radic Biol Med 20 (1996), 933-956.
39. P.M. Ridker, D.E. Vaughan, M.J. Stampfer, R.J. Glynn and C.H. Hennekens, Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator, J Am Med Ass 272 (1994), 929-933.
40. E.B. Rimm, A. Klatsky, D. Grobbee and M.J. Stampfer, Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or spirits, Br Med J 312 (1996), 731-736.
41. R. Ross, The pathogenesis of atherosclerosis: a perspective for the 1990 s, Nature 362 (1993), 801-809.
42. M. Sato, P.S. Ray, G. Maulik, N. Maulik, R.M. Engelman, A.A. Bertelli, A. Bertelli and D.K. Das, Myocardial protection with red wine extract, J Cardiovasc Pharmacol 35 (2000), 263-268.
43. M. Serafini, G. Maiani and A. Ferro-Luzzi, Alcohol-free red wine enhances plasma antioxidant capacity in humans, J Nutr 128 (1998), 1003-1007. (Pubitemid 28280200)
44. G.J. Soleas, E.P. Diamandis and D.M. Goldberg, Wine as a biological fluid: history, production, and role in disease prevention, J Clin Lab An 11 (1997), 287-313.
45. P.L. Teissedre, E.N. Frankel, A.L. Waterhouse, H. Peleg and J.B. German, Inhibition of in vitro human LDL oxidation by phenolic antioxidants from grapes and wines, J Sci Food Agri 70 (1996), 55-61.
46. B. Turczýnski, B. Chmiel, L. Słowínska and Z. Olszowy, The influence of controlled ethanol consumption on whole blood and plasma viscosity, Wiad Lek 54 (2001), 409-417.
47. A. Vaya, C. Falco, P. Fernandez, T. Contreras, M. Valls and J. Aznar, Erythrocyte aggregation determined with the Myrenne aggregometer at two modes (M0, M1) and at two times (5 and 10 sec), Clin Hemorheol Microcirc 29 (2003), 119-127.
48. T. Walle, F. Hsieh, M.H. de Legge, J.E. Oatis Jr. and U.K. Walle, High absorption but very low bioavailability of oral resveratrol in humans, Drug Metab Dispos 32 (2004), 1377-1382.
49. J.M. Yuan, R.K. Ross, Y.T. Gao, B.E. Henderson and M.C. Yu, Follow up study of moderate alcohol intake and mortality among middle aged men in Shanghai, China, Br Med J 314 (1997), 18-23.
50. A.M. Zeiher, H. Drexler, B. Saurbier and H. Just, Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension, J Clin Invest 92 (1993), 652-662.